U.S. Physical Therapy (NYSE:USPH – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.
Other research analysts also recently issued reports about the company. Barrington Research raised their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a research note on Friday, August 8th. Zacks Research raised shares of U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $110.25.
Get U.S. Physical Therapy alerts:
Check Out Our Latest Report on USPH
U.S. Physical Therapy Stock Performance
Shares of USPH opened at $80.66 on Friday. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of 35.22, a PEG ratio of 4.02 and a beta of 1.47. U.S. Physical Therapy has a 12 month low of $62.77 and a 12 month high of $101.19. The firm has a fifty day simple moving average of $79.97 and a 200 day simple moving average of $76.46. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. During the same period in the previous year, the business earned $0.73 EPS. The company’s revenue was up 18.0% compared to the same quarter last year. Research analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.
Insider Activity
In other news, COO Graham D. Reeve sold 763 shares of the company’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $84.97, for a total transaction of $64,832.11. Following the completion of the sale, the chief operating officer owned 21,483 shares of the company’s stock, valued at approximately $1,825,410.51. This represents a 3.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Carey P. Hendrickson sold 698 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the transaction, the chief financial officer owned 27,808 shares of the company’s stock, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,853 shares of company stock worth $581,406. 2.00% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in USPH. Osaic Holdings Inc. grew its holdings in shares of U.S. Physical Therapy by 1.6% during the 2nd quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock valued at $817,000 after purchasing an additional 166 shares during the last quarter. State of Wyoming boosted its position in U.S. Physical Therapy by 85.3% in the second quarter. State of Wyoming now owns 1,575 shares of the company’s stock valued at $123,000 after buying an additional 725 shares in the last quarter. Public Sector Pension Investment Board grew its stake in shares of U.S. Physical Therapy by 8.2% during the second quarter. Public Sector Pension Investment Board now owns 51,820 shares of the company’s stock worth $4,052,000 after buying an additional 3,933 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of U.S. Physical Therapy by 377.0% during the second quarter. Tower Research Capital LLC TRC now owns 1,746 shares of the company’s stock worth $137,000 after buying an additional 1,380 shares in the last quarter. Finally, Corient Private Wealth LLC boosted its holdings in shares of U.S. Physical Therapy by 163.6% during the 2nd quarter. Corient Private Wealth LLC now owns 9,896 shares of the company’s stock valued at $774,000 after acquiring an additional 6,142 shares in the last quarter.
U.S. Physical Therapy Company Profile
(Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Stories
Five stocks we like better than U.S. Physical Therapy
What is the Hang Seng index?
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside
What Investors Must Know About Over-the-Counter (OTC) Stocks
Football Season Is Here and DraftKings Stock Is Surging
How to trade using analyst ratings
RH Stock Slides After Mixed Earnings and Tariff Concerns